Form 4: Hologic Inc. Merger Completes, Ownership Changes Reported

Hologic Inc. has completed its merger, with reporting person Nanaz Mohtashami no longer beneficially owning direct or indirect shares following the transaction.

Summary

• This filing reports changes in beneficial ownership for Nanaz Mohtashami, a Director at Hologic Inc. (HOLX).
• The changes are a result of the merger between Hologic, Inc. and Hopper Parent Inc., which became effective on April 7, 2026.
• Following the merger, each share of Hologic common stock was converted into $76.00 in cash and one contingent value right (CVR) potentially worth up to $3.00.
• Nanaz Mohtashami no longer beneficially owns any shares of Hologic common stock directly or indirectly.
• Outstanding stock options were cancelled and converted into cash payments and/or CVRs based on their exercise price relative to the merger consideration.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it primarily reports on the completion of a merger and the resulting changes in beneficial ownership, rather than new operational or financial performance data.

Positives

• The merger was completed, providing shareholders with cash consideration and potential additional value through CVRs.
• The transaction offers a clear exit for shareholders at a specified price ($76.00 per share plus CVRs).

Negatives

• The company is no longer publicly traded as a separate entity, changing its ownership structure and reporting obligations.
• The value of the CVRs is contingent and not guaranteed, introducing an element of uncertainty for former shareholders.

Risks

• The contingent value rights (CVRs) may not reach their maximum payout of $3.00 per share, depending on future performance or events.
• The cancellation of stock options for cash and CVRs means that holders of these options will not benefit from any potential future appreciation of Hologic's stock if it were to continue as a public entity.

Future Outlook

The future outlook for Hologic Inc. as a standalone public entity is no longer applicable due to the completion of the merger. The focus shifts to the performance and payout of the contingent value rights (CVRs).

Management Comments

• Nanaz Mohtashami, a Director, no longer beneficially owns any shares of Company Common Stock directly or indirectly as a result of the Merger.
• Outstanding stock options were cancelled and converted into cash and/or CVRs based on their exercise price relative to the merger consideration.

Industry Context

StockSavvy.ai notes that this Form 4 filing reflects a significant corporate event, the completion of a merger, which is a common strategy in the healthcare technology sector for consolidation or to unlock shareholder value. The structure of the deal, including cash and contingent value rights, is a typical approach in such transactions.

Stakeholder Impact

• Shareholders: Receive $76.00 per share in cash and one CVR per share, providing a liquidity event.
• Option Holders: Outstanding options are cancelled and converted into cash and/or CVRs.
• Employees: May experience changes in employment terms or roles under the new ownership structure.
• Creditors: The merger terms will impact the capital structure and debt obligations of the combined entity.

Next Steps

• Shareholders will receive the cash consideration and CVRs as per the merger agreement.
• The performance and potential payout of the CVRs will be monitored.

Key Dates

Keywords

Hologic Inc., HOLX, Merger, Form 4, Beneficial Ownership, SEC Filing, Nanaz Mohtashami, Contingent Value Right, Stock Options, Corporate Action